XEOMIN® Safety | Adults With Blepharospasm

Adults With Blepharospasm

Demonstrated Safety in Adults With Blepharospasm

Adverse Reactions Pinch to zoom Adverse Reactions pre-treated with Botox Pinch to zoom Adverse Reactions with Botox Pinch to zoom

*Including vision blurred.

The potency Units of XEOMIN are specific to the preparation and assay method utilized. They are not interchangeable with the other preparations of botulinum toxin products and, therefore, Units of biological activity of XEOMIN cannot be compared to or converted into Units of any other botulinum toxin products assessed with any other specific assay method.

Most adverse reactions were mild or moderate2

References

  1. XEOMIN® [Package insert]. Raleigh, NC: Merz Pharmaceuticals, LLC; 2019.
  2. Roggenkämper P, Jost WH, Bihari K, Comes G, Grafe S; for the NT 201 Blepharospasm Study Team. Efficacy and safety of a new botulinum toxin type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm (Vienna). 2006;113(3):303–312.